Useful resources |
Tegaserod for the treatment of irritable bowel syndrome (Cochrane Review) ABSTRACT Background: IBS is a complex disorder that encompasses a wide profile of symptoms. Current drug treatments for irritable bowel syndrome (IBS) are of limited value. Many target specific symptoms only. Tegaserod, a 5HT4 partial agonist, represents a novel mechanis . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |